首页|期刊导航|河南中医|电针联合叩刺拔罐治疗带状疱疹后遗神经痛瘀血阻络证疗效观察

电针联合叩刺拔罐治疗带状疱疹后遗神经痛瘀血阻络证疗效观察OA

Clinical Efficacy Observation of Electroacupuncture Combined with Tapping and Cupping Therapy in the Treatment of Postherpetic Neuralgia with Blood Stasis Blocking Collaterals Syndrome

中文摘要英文摘要

目的:观察电针联合叩刺拔罐治疗带状疱疹后遗神经痛(postherpetic neuralgia,PHN)瘀血阻络证的临床疗效及其对患者P 物质(substance P,SP)、脑源性神经营养因子(brain-derived neurotrophic factor,BDNF)、酪氨酸激酶受体 B(tropomyosin re-ceptor kinase B,TrkB)水平的影响.方法:将90 例 PHN 患者按照随机数字表法分为对照组和观察组,每组各45 例.对照组给予加巴喷丁胶囊,观察组在对照组治疗的基础上联合电针及叩刺拔罐疗法.比较两组患者的临床疗效、不良反应发生率及治疗前后中医证候积分、视觉模拟评分(visual analogue scale,VAS)、匹兹堡睡眠质量指数(pittsburgh sleep quality index,PSQI)评分、36 条目健康调查简表(the 36-item short form health survey,SF-36)评分、血清生物标志物(SP、BDNF、TrkB)、Th1/Th2 细胞因子指标[(干扰素-γ(interferon-γ,IFN-γ)、白细胞介素(interleukin,IL)-2、肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)、IL-4、IL-6、IL-10、Th1/Th2 比值]变化情况.结果:两组患者治疗后刺痛、面色晦暗、夜寐不安、舌质紫暗或有瘀斑等中医证候积分低于本组治疗前,且观察组低于对照组,差异具有统计学意义(P<0.05).两组患者治疗后 VAS 评分、PSQI 评分低于本组治疗前,SF-36 评分高于本组治疗前,且治疗后组间比较,差异具有统计学意义(P<0.05).两组患者治疗后 SP 低于本组治疗前,BDNF、TrkB 高于本组治疗前,且治疗后组间比较,差异具有统计学意义(P<0.05).两组患者治疗后 IFN-γ、IL-2、TNF-α、Th1/Th2 低于本组治疗前,IL-4、IL-10 高于本组治疗前,且治疗后组间比较,差异具有统计学意义(P<0.05).观察组有效率为93.33%,对照组有效率为77.78%,两组有效率比较,差异具有统计学意义(P<0.05).两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:电针联合叩刺拔罐治疗 PHN 瘀血阻络证,能够缓解患者的临床症状,改善睡眠质量,提高生活质量,其作用机制可能与调节 BDNF/TrkB 信号通路,重塑 Th1/Th2 免疫平衡有关.

Objective:To observe the clinical efficacy of electroacupuncture combined with tapping and cupping therapy in the treatment of postherpetic neuralgia(PHN)with blood stasis blocking collaterals syndrome and its effects on substance P(SP),brain-derived neurotrophic factor(BDNF),and tropomyosin receptor kinase B(TrkB)levels in patients.Methods:A total of 90 PHN patients were randomly divided into the control group and the observation group using the random number table method,with 45 cases in each group.The control group received Gabapentin Capsules,while the observation group further received electroacupuncture and tapping-cupping therapy on the basis of the control group.Then clinical efficacy,incidence of adverse reactions,as well as changes in TCM syndrome scores,visual analogue scale(VAS)scores,Pittsburgh sleep quality index(PSQI)scores,36-item Short Form Health Survey(SF-36)scores,serum biomarker levels(SP,BDNF,TrkB),and Th1/Th2 cytokine indexes[interferon-gamma(IFN-γ),interleukin(IL)-2,tumor necrosis factor-alpha(TNF-α),IL-4,IL-6,IL-10,and Th1/Th2 ratio]before and after treatment were compared between the two groups.Results:After treatment,both groups showed significant reductions in TCM syndrome scores,such as stabbing pain,dull com-plexion,restless sleep,dark purple tongue or petechiae),and the above scores in the observation group were lower than those in the con-trol group,with statistically significant differences(P<0.05).After treatment,VAS and PSQI scores decreased,while SF-36 scores in-creased in both groups,statistically significant differences(P<0.05).SP levels decreased,while BDNF and TrkB levels increased in the two groups,with statistically significant differences(P<0.05).IFN-γ,IL-2,TNF-α,and the Th1/Th2 ratio decreased,whereas IL-4 and IL-10 levels increased in the two groups,with statistically significant differences(P<0.05).The effective rate was93.33%in the observation group and 77.78%in the control group respectively,with a statistically significant difference(P<0.05).However,no significant difference was observed in the incidence of adverse reactions between the two groups(P>0.05).Conclusion:Electroacu-puncture combined with tapping and cupping therapy for PHN with blood stasis blocking collaterals syndrome can alleviate clinical symptoms,improve sleep quality,and enhance quality of life of patients.The underlying mechanism may involve regulating the BDNF/TrkB axis signaling pathway and restoring Th1/Th2 immune balance.

吴潇;王文斌;蒋西玲

南阳市第二人民医院,河南 南阳 473000南阳市第二人民医院,河南 南阳 473000南阳市第二人民医院,河南 南阳 473000

医药卫生

带状疱疹后遗神经痛瘀血阻络证电针叩刺疗法拔罐疗法神经病理性疼痛

postherpetic neuralgia(PHN)blood stasis blocking collaterals syndromeelectroacupuncturetapping therapycupping therapyneuropathic pain

《河南中医》 2026 (6)

821-827,7

2023年河南省医学科技攻关计划项目(LHGJ202309632)

10.16367/j.issn.1003-5028.2026.06.0135

评论